Sugars: Clinical Trials

175 trials of Sugars, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

121 completed, 27 terminated, 17 unknown, 7 withdrawn. 175 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4175Completed 121, Terminated 27, Unknown 17, Withdrawn 7, Recruiting 2, Active not recruiting 1

Follow Sugars: new trials by email Literature Review of Sugars trials Research Report on Sugars

Trials (filtered) newest first · largest first

All 175 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role Of Sensitivity to neuroEndocrine Systems in Social Decisions
Hydrocortisone, Yohimbine, Placebo - Borderline Personality Disorder
Phase 4WithdrawnUniversity of North Carolina, Chapel Hill2024-07-012024-06-05
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
Propranolol, Placebo - Cardiovascular Disease
Phase 4RecruitingUniversity of North Carolina, Chapel Hill1202024-05-012026-11-05
Over-the-Counter Antihistamines & Heat Stress
50 mg Diphenhydramine, 10 mg Loratadine, 5 mg Desloratadine - Heat Illness, Allergic Rhinitis
Phase 4UnknownLakehead University162023-12-052024-01-22
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Nicotinamide riboside, Placebo - Aging
Phase 4RecruitingUniversity of Oklahoma2142023-05-032026-04-01
Duloxetine Tibial Plateau
Duloxetine, Placebo, Standard of care (SOC) for tibial plateau surgery - Tibial Plateau Fracture, Pain, Postoperative
Phase 4WithdrawnBoston Medical Center2022-10-012022-11-21
Brain and Stress Study
Minocycline, Placebo - Stress, Psychological, Motivation
Phase 4CompletedUniversity of North Carolina, Chapel Hill102022-09-122024-12-18
Sublingual Apomorphine in Refractory Restless Legs Syndrome
Apomorphine Sublingual Film, Placebo - Restless Legs Syndrome
Phase 4UnknownWilliam Ondo, MD162022-09-012022-09-06
Oral Amiodarone for Acute Cardioversion of Atrial Fibrillation Study
Amiodarone Hydrochloride, Placebo - Atrial Fibrillation
Phase 4TerminatedUniversity of Calgary32022-02-032026-02-05
Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach
Estradiol Transdermal Patch 0.1 mg/24 hrs, Oral Micronized Progesterone 200mg, Inactive Clear Patch - Suicidal Ideation
Phase 4CompletedUniversity of Illinois at Chicago1242020-09-152025-12-19
Effects of Tetrahydrobiopterin (BH4) on Leg Blood Flow and Exercise Capacity in Patients With Peripheral Artery Disease
Sapropterin Dihydrochloride (BH4, tetrahydrobiopterin), Placebo - Peripheral Artery Disease, Peripheral Arterial Disease
Phase 4WithdrawnUniversity of Nebraska2019-07-012024-09-03
Evaluation of the Effects of Pre-operative Deflazacort on Post-operative Pain, Edema and Trismus
Deflazacort 30 MG Oral Tablet, Sugar pill - Impacted Third Molar Tooth
Phase 4UnknownYuzuncu Yil University352018-12-152023-08-22
The Effect of Tablet Size on Cognitive Performance Caffeine
Caffeine Anhydrous with small sucrose pill, Placebo - large sucrose pill, Caffeine Anhydrous with large sucrose pill - Placebo Effect
Phase 4CompletedUniversity of Colorado, Denver1202018-10-312019-04-17
Brain Perfusion & Oxygenation in Parkinson's Disease With NOH
Droxidopa, Placebo - Parkinson Disease, Neurogenic Orthostatic Hypotension
Phase 4CompletedWilliam Ondo, MD172018-08-232022-09-06
Unique Effects of Perimenstrual Estradiol or Progesterone Supplementation on Perimenstrual Suicidality
Transdermal Estradiol + Placebo, Oral Micronized Progesterone + Placebo, Placebos - Suicidal Ideation
Phase 4CompletedUniversity of Illinois at Chicago602018-07-272022-09-14
Effect of Combined Morphine and Duloxetine on Chronic Pain
Morphine, Duloxetine, Placebo - Chronic Low Back Pain, Chronic Neck Pain
Phase 4CompletedMassachusetts General Hospital812018-03-122024-11-14
IMProving Executive Function Study
Lisdexamfetamine, Placebo oral capsule - Cognitive Impairment, RRSO
Phase 4CompletedUniversity of Pennsylvania692017-09-222023-11-18
Mirabegron for Treatment of Overactive Bladder Symptoms in Patients With Parkinson's Disease
Mirabegron, Placebo - Overactive Bladder, Parkinson Disease
Phase 4UnknownSeoul National University Hospital1442017-07-172018-01-30
Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study
Placebo Oral Capsule, Dronabinol Cap 5 milligrams (MG), Dronabinol Cap 10 milligrams (MG) - PostTraumatic Stress Disorder
Phase 4CompletedWayne State University462017-06-012025-08-22
A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia
Suvorexant, Placebo - Multiple Sclerosis, Fatigue
Phase 4CompletedTheodore R. Brown, MD MPH362017-03-282025-02-03
Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients
MOVANTIKā„¢ (naloxegol), Sugar Pill - Constipation
Phase 4TerminatedMassachusetts General Hospital532017-01-012019-09-10

Showing 20 of 175. Sign in to see all of them.

Conditions studied

Depression (13)  ·  Pain (10)  ·  Bipolar Disorder (9)  ·  Obesity (8)  ·  Parkinson Disease (8)  ·  Attention Deficit Disorder with Hyperactivity (7)  ·  Schizophrenia (7)  ·  Alcoholism (6)  ·  Depressive Disorder, Major (6)  ·  Psychotic Disorders (6)  ·  Stress Disorders, Post-Traumatic (6)  ·  Cognitive Dysfunction (5)  ·  Fatigue (5)  ·  Sleep Initiation and Maintenance Disorders (5)  ·  Agnosia (4)

Sponsors

University of North Carolina, Chapel Hill (7)  ·  Massachusetts General Hospital (6)  ·  New York State Psychiatric Institute (6)  ·  University of Texas Southwestern Medical Center (6)  ·  Northwestern University (4)  ·  Johns Hopkins University (3)  ·  University of California, San Francisco (3)  ·  University of Colorado, Denver (3)  ·  University of Illinois at Chicago (3)  ·  University of Michigan (3)  ·  University of Nebraska (3)  ·  University of Pennsylvania (3)  ·  Dr. Stephen Freedman (2)  ·  M.D. Anderson Cancer Center (2)  ·  NYU Langone Health (2)

Countries

United States (133)  ·  Canada (9)  ·  Australia (3)  ·  Norway (3)  ·  United Kingdom (3)  ·  Austria (2)  ·  China (2)  ·  Pakistan (2)  ·  South Korea (2)  ·  Finland (1)  ·  France (1)  ·  Israel (1)  ·  Mexico (1)  ·  Singapore (1)  ·  Sweden (1)

Top investigators

Apkar Apkarian, PhD (2)  ·  Donald C Goff, MD (2)  ·  Keely Muscatell, PhD (2)  ·  Peter D Reaven, MD (2)  ·  Sajid B Soofi, MD (2)  ·  Sherwood Brown, MD, PhD (2)  ·  Stephen Freedman, MD (2)  ·  Tory A Eisenlohr-Moul, PhD (2)  ·  William Ondo, MD (2)  ·  Zulfiqar Bhutta, MD (2)  ·  Abdulla K. Salahudeen, MD (1)  ·  Ahmad M Slim, MD (1)  ·  Andrew A. Nierenberg, M.D. (1)  ·  Andrew D Goodman, MD (1)  ·  Andrew Miller, MD (1)

Results publications

PMID 34433773, PMID 36269595, PMID 36999619, PMID 37142273, PMID 10598635, PMID 12670812, PMID 15275765, PMID 16679671, PMID 17251278, PMID 18700421, PMID 19577749, PMID 20492840, PMID 21346734, PMID 21777715, PMID 21923696, PMID 22353759, PMID 22393222, PMID 23186950, PMID 23575741, PMID 23788218, PMID 23870503, PMID 24290461, PMID 24345758, PMID 24606117, PMID 24890531, PMID 25760804, PMID 25970252, PMID 25998279, PMID 26063677, PMID 26115513, PMID 26227019, PMID 26237520, PMID 26351969, PMID 26414990, PMID 26731446, PMID 26745211, PMID 27117285, PMID 27550732, PMID 27733180, PMID 27788130, PMID 28012485, PMID 28652290, PMID 28778815, PMID 28861338, PMID 29030421, PMID 29432967, PMID 29478970, PMID 29588126, PMID 29671676, PMID 29773079

NIH funding

R01AT007987 (2), R01MH072383 (2), 2009 (1), 2015 (1), I21RX002180 (1), K23DK106520 (1), K23HL093214 (1), K23HL119602 (1), K99MH109667 (1), P50HL084945 (1), P50NS062684 (1), P60AA003510 (1), R00MH102349 (1), R00MH109667 (1), R01AA013379 (1)